Nachrichten zur MacroGenics Inc. Aktie

Why Shares of MacroGenics Climbed Thursday

The cancer-focused biotech delivered a strong earnings report....…

MacroGenics stock climbs ~10% as FY22 revenue rises beating estimates

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics (MGNX) Q4 2022 Earnings Call Transcript

MGNX earnings call for the period ending December 31, 2022....…

MacroGenics GAAP EPS of -$1.95 misses by $0.07, revenue of $151.94M beats by $1.88M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Senior VP and General Counsel verkauft Aktien von MacroGenics im Wert von 32.393$

Peters, Jeffrey Stuart - Vorstand - Tag der Transaktion: 2023-03-10...…

MacroGenics expands license agreement with Synaffix

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MACROGENICS INC For: Mar 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Shares Drop 12% After Thursday Move Higher

MacroGenics Shares Drop 12% After Thursday Move Higher...…

Why Shares of MacroGenics Jumped Thursday

The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy....…

MacroGenics Shares Rise 16% After Sale of Tzield Royalty Interest

MacroGenics Shares Rise 16% After Sale of Tzield Royalty Interest...…

MacroGenics unloads TZIELD royalty stake for up to $200M to a unit of DRI

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million

ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call

ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, March 02, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on…

Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength?

MacroGenics (MGNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 2.532.600$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-02-14...…

MacroGenics phase 1 prostate cancer asset data leads to phase 2 initiation later in 2023

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium

ROCKVILLE, MD, Feb. 13, 2023 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on…

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 794.925$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-01-19...…

MacroGenics (MGNX) Stock Sinks As Market Gains: What You Should Know

MacroGenics (MGNX) closed the most recent trading day at $5.70, moving -0.35% from the previous trading session....…

MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference

ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on…

MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors

ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 1.121.800$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-12-27...…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 1.176.800$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-12-23...…

Form 8-K MACROGENICS INC For: Dec 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MACROGENICS INC For: Dec 14

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights MacroGenics, NerdWallet and Euronav

MacroGenics, NerdWallet and Euronav have been highlighted in this Screen of The Week article....…

Can MacroGenics (MGNX) Climb 74% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 73.9% in MacroGenics (MGNX). While…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 1.788.180$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-11-22...…

MacroGenics cut to Neutral at Citi, Guggenheim upgrades

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics down 18% as Cowen downgrades on lack of catalysts

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Shares of MacroGenics Were Dropping Tuesday

Profit-taking and an analyst downgrade affected the stocks price....…

Palisade, Timber top healthcare gainers; MacroGenics, Gamida among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson

MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson have been highlighted in this Screen of The Week article....…

MacroGenics to get $60M milestone from Provention as FDA approves diabetes drug Tzield

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on…

5 Best Stocks to Invest in for Solid Earnings Acceleration

Invest in stocks like MacroGenics (MGNX), NerdWallet (NRDS) & LivePerson (LPSN) at the moment for superb earnings acceleration....…

Why MacroGenics Stock Crushed the Market on Monday

Positive momentum continues for the cancer specialist in the wake of its latest earnings report....…

Why MacroGenics Stock Popped Again Today

Investors and analysts alike are getting more bullish on the company in the wake of its third-quarter results....…

Why MacroGenics Stock Blasted Higher Today

A quarter that was far better than expected gets investors excited about the biotech at the end of the week....…

MacroGenics (MGNX) Q3 2022 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2022....…

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Nov. 02, 2022 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call

ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying

The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 623.919$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-10-19...…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 1.143.565$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-10-20...…

Analyst Ratings for Macrogenics

Over the past 3 months, 5 analysts have published their opinion on Macrogenics (NASDAQ:MGNX) stock. These analysts are typically employed…

Form 8-K MACROGENICS INC For: Oct 17

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about buying stock in MacroGenics, Anavex Life Sciences, Uber Technologies, IVERIC bio, or Roblox?

NEW YORK,, Oct. 17, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MGNX, AVXL, UBER, ISEE, and RBLX. To…